Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for corrigendum to 46th Annual Report of the Company
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has published a corrigendum (notice of corrections) to its 46th Annual Report in newspapers, as informed to the stock exchange. A corrigendum is issued when errors, omissions, or corrections need to be made to a previously published annual report. This is typically a routine regulatory compliance filing under SEBI listing requirements. Shareholders and investors can refer to the company's website or the stock exchange for the detailed corrigendum document to understand what specific changes were made. No major corporate event, fundraising, or strategic change is implied by this filing.
This is a routine administrative correction and is unlikely to have any material impact on the stock price or shareholder value. Investors should simply review the corrigendum to be aware of any revised disclosures in the annual report.